decisionhealth Newsletters, Answer Books - 2008 Issue 5 (May)
Answer_Book / Advance_Beneficiary_Notice_of_Noncoverage / 11 ABN not needed for self-injectible drugs
Subscribe or sign in to view the full article.
Article Overview
This Find-A-Code article reviews when an advance beneficiary notice is not required for certain self-injectable drugs under Medicare policy. It is aimed at billing, coding, and reimbursement professionals who need a high-level understanding of Medicare coverage exclusions, carrier determinations, and related administrative guidance.
Why This Topic Matters
Understanding this policy helps practices handle patient billing and coverage communication consistently when drugs are excluded from Medicare coverage under self-administration rules. It also highlights the role of carrier guidance and Medicare administrative policy in determining when notice requirements apply.
Article Sections
-
ABN not needed for self-injectible drugs
Overview of the Medicare coverage topic and when advance notice is discussed in connection with excluded drugs.
-
Policy clarifications
Additional administrative guidance about carrier notice timing, website information, and how coverage decisions are determined.
What You Will Learn
- The Medicare coverage context for self-injectable drugs
- When advance beneficiary notice is discussed in relation to excluded drugs
- How carrier guidance affects coverage determinations
- What kinds of administrative clarifications accompany this policy
Who Should Read This
- Medical coders
- Billing staff
- Reimbursement specialists
- Practice administrators
- Compliance staff
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com